SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Nov-20 11:14 AM View: | F-Star Therapeutics, Inc. (FSTX) | 20-Nov-20 | Market Option Sale | 175 | $4.76 | $833.00 | (< 1%) 47.6K to 47.42K | |
23-Nov-20 11:14 AM View: | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Grant | 15,000 | -- | -- | 66% 22.6K to 37.6K | |
23-Nov-20 11:14 AM View: | F-Star Therapeutics, Inc. (FSTX) | 19-Nov-20 | Option Exercise | 10,000 | -- | -- | 27% 37.6K to 47.6K | |
14-Nov-19 8:46 AM View: | F-Star Therapeutics, Inc. (FSTX) | 13-Nov-19 | Market Purchase | 5,000 | $2.83 | $14,150.00 | 6% 85.4K to 90.4K | (10%) |
29-May-19 11:22 AM View: | F-Star Therapeutics, Inc. (FSTX) | 29-May-19 | Market Purchase | 10,000 | $6.03 | $60,300.00 | 13% 75.4K to 85.4K | (57%) |
22-May-19 9:10 AM View: | F-Star Therapeutics, Inc. (FSTX) | 21-May-19 | Market Purchase | 5,000 | $6.63 | $33,150.00 | 7% 70.4K to 75.4K | (61%) |
30-Apr-19 3:17 PM View: | F-Star Therapeutics, Inc. (FSTX) | 30-Apr-19 | Market Purchase | 10,000 | $7.34 | $73,350.00 | 17% 60.4K to 70.4K | (65%) |
13-Aug-18 4:04 PM View: | F-Star Therapeutics, Inc. (FSTX) | 13-Aug-18 | Market Purchase | 4,000 | $12.02 | $48,080.00 | 7% 56.4K to 60.4K | (79%) |
01-Mar-18 4:01 PM View: | F-Star Therapeutics, Inc. (FSTX) | 28-Feb-18 | Market Purchase | 1,000 | $12.83 | $12,830.00 | 2% 55.4K to 56.4K | (80%) |
14-Sep-17 4:03 PM View: | F-Star Therapeutics, Inc. (FSTX) | 14-Sep-17 | Market Purchase | 1,000 | $14.84 | $14,840.00 | 2% 54.4K to 55.4K | (83%) |
03-Aug-17 4:02 PM View: | F-Star Therapeutics, Inc. (FSTX) | 03-Aug-17 | Market Purchase | 2,000 | $12.35 | $24,710.00 | 4% 52.4K to 54.4K | (79%) |
06-Apr-17 8:00 PM View: | Metastat, Inc. (MTST) | 04-Apr-17 | Purchase | 20,000 | -- | -- | 68% 29.62K to 49.62K | |
07-Mar-17 4:57 PM View: | F-Star Therapeutics, Inc. (FSTX) | 07-Mar-17 | Market Purchase | 2,000 | $9.44 | $18,880.00 | 4% 50.4K to 52.4K | (73%) |
16-Dec-16 10:28 AM View: | F-Star Therapeutics, Inc. (FSTX) | 15-Dec-16 | Market Purchase | 2,000 | $8.50 | $17,000.00 | 4% 48.4K to 50.4K | (69%) |
01-Dec-16 4:07 PM View: | F-Star Therapeutics, Inc. (FSTX) | 30-Nov-16 | Market Purchase | 2,000 | $7.98 | $15,960.00 | 4% 46.4K to 48.4K | (67%) |
23-Nov-16 4:00 PM View: | F-Star Therapeutics, Inc. (FSTX) | 23-Nov-16 | Grant | 21,900 | $9.12 | $199,728.00 | 89% 24.5K to 46.4K | (72%) |
10-Nov-16 5:01 PM View: | F-Star Therapeutics, Inc. (FSTX) | 09-Nov-16 | Market Purchase | 2,000 | $8.84 | $17,680.00 | 9% 22.5K to 24.5K | (69%) |
05-Dec-16 7:19 PM View: | Metastat, Inc. (MTST) | 30-Oct-16 | Private Purchase | 28,342 | $2.00 | $56,684.00 | 2225% 1.27K to 29.62K | |
02-Sep-16 4:11 PM View: | F-Star Therapeutics, Inc. (FSTX) | 02-Sep-16 | Market Purchase | 1,000 | $11.75 | $11,750.00 | 5% 21.5K to 22.5K | (77%) |
31-Aug-16 4:07 PM View: | F-Star Therapeutics, Inc. (FSTX) | 30-Aug-16 | Market Purchase | 1,000 | $12.41 | $12,410.00 | 5% 20.5K to 21.5K | (78%) |
22-Aug-16 5:46 PM View: | F-Star Therapeutics, Inc. (FSTX) | 22-Aug-16 | Market Purchase | 1,000 | $11.66 | $11,660.00 | 5% 19.5K to 20.5K | (77%) |
22-Aug-16 5:46 PM View: | F-Star Therapeutics, Inc. (FSTX) | 19-Aug-16 | Market Purchase | 1,000 | $11.20 | $11,200.00 | 5% 18.5K to 19.5K | (76%) |
16-Aug-16 5:34 PM View: | F-Star Therapeutics, Inc. (FSTX) | 16-Aug-16 | Market Purchase | 1,000 | $11.37 | $11,370.00 | 6% 17.5K to 18.5K | (76%) |
16-Aug-16 5:34 PM View: | F-Star Therapeutics, Inc. (FSTX) | 15-Aug-16 | Market Purchase | 1,000 | $11.20 | $11,200.00 | 6% 16.5K to 17.5K | (76%) |
09-Aug-16 1:29 PM View: | F-Star Therapeutics, Inc. (FSTX) | 09-Aug-16 | Market Purchase | 2,000 | $11.02 | $22,050.00 | 14% 14.5K to 16.5K | (75%) |
05-Aug-16 5:53 PM View: | F-Star Therapeutics, Inc. (FSTX) | 04-Aug-16 | Market Purchase | 2,000 | $9.96 | $19,920.00 | 16% 12.5K to 14.5K | (73%) |
12-May-16 6:38 PM View: | F-Star Therapeutics, Inc. (FSTX) | 11-May-16 | Purchase | 12,500 | $12.00 | $150,000.00 | 100% 0 to 12.5K | |
06-Aug-15 7:01 PM View: | Metastat, Inc. (MTST) | 05-Aug-15 | Market Purchase | 9,100 | $0.28 | $2,507.00 | 91% 10.0K to 19.1K | (69%) |
26-Jun-15 7:25 PM View: | Metastat, Inc. (MTST) | 25-Jun-15 | Market Purchase | 10,000 | $0.35 | $3,535.00 | 100% 0 to 10.0K | (76%) |
02-Jul-10 3:19 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 02-Jul-10 | Disposition | 239,053 | $2.20 | $525,917.00 | (100%) 239.05K to 0 | 0% |
23-Mar-10 4:35 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 19-Mar-10 | Market Purchase | 22,181 | $1.30 | $28,868.60 | 10% 214.37K to 236.55K | 69% |
17-Feb-10 6:23 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 12-Feb-10 | Market Purchase | 6,331 | $1.27 | $8,040.37 | 3% 188.15K to 194.48K | 73% |
05-May-09 5:22 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 01-May-09 | Grant | 104,167 | -- | -- | 124% 83.98K to 188.15K | |
26-Jun-08 7:23 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 26-Jun-08 | Market Purchase | 30,000 | $2.32 | $69,600.00 | 58% 51.49K to 81.49K | (25%) |
15-May-08 10:44 AM View: | Javelin Pharmaceuticals, Inc. (JAV) | 13-May-08 | Private Purchase | 41,493 | $2.41 | $99,998.10 | 100% 0 to 41.49K | 37% |
09-Nov-07 6:57 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 08-Nov-07 | Market Purchase | 10,000 | $4.40 | $43,972.00 | (78%) 12.8K to 2.8K | 60% |
15-May-06 10:57 AM View: | Genta Inc De/ (GNTA) | 12-May-06 | Market Purchase | 15,000 | $1.46 | $21,900.00 | 100% 0 to 15.0K | (96%) |